CD4 and familial pancreatic carcinoma: Our study supports this viewpoint, suggesting an inverse correlation between HLA-DR+ CD4+ antigen-presenting cells and pancreatic cancer (ORIVW=0.920, 95%CI=0.873–0.968) (Figure 3B).